ALX ONCOLOGY HOLDINGS INC - ALXO
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover GP II, LLC | 2.1% | 2,827,739 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover Fund II, L.P. | 2.1% | 2,827,739 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover GP III, LLC | 2.1% | 2,827,748 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TCG Crossover Fund III, L.P. | 2.1% | 2,827,748 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Chen Yu | 4.2% | 5,655,487 | View |
| Jul 27, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.4% | 7,327,850 | View |
| May 27, 2026 | SCHEDULE 13D/A | — | — | — | View |
| May 15, 2026 | SCHEDULE 13G/A | HBM Healthcare Investments (Cayman) Ltd. | 6.5% | 8,590,692 | View |
| May 15, 2026 | SCHEDULE 13G/A | Redmile Group, LLC | 6.8% | 9,214,188 | View |
| May 15, 2026 | SCHEDULE 13G/A | Jeremy C. Green | 6.8% | 9,214,188 | View |
| May 15, 2026 | SCHEDULE 13G/A | Redmile Biopharma Investments III, L.P. | 3.9% | 5,267,838 | View |
| Apr 28, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 0.5% | 730,528 | View |
| Apr 28, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 1.5% | 1,988,559 | View |
| Apr 28, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 1.5% | 1,988,559 | View |
| Apr 28, 2026 | SCHEDULE 13G/A | Israel A. Englander | 1.5% | 1,988,559 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.